Tanshinone IIA promotes the differentiation of bone marrow mesenchymal stem cells into neuronal‑like cells in a spinal cord injury model

J Transl Med, 2018 · DOI: https://doi.org/10.1186/s12967-018-1571-y · Published: July 7, 2018

Spinal Cord Injury Alternative Medicine Regenerative Medicine & Stem Cells

Simple Explanation

Spinal cord injury (SCI) is a severe central nervous system injury, and bone marrow mesenchymal stem cell (BMSC) transplantation is a potential treatment. Tanshinone IIA (TIIA), extracted from Salvia miltiorrhiza Bunge, may protect against SCI. This study explores if TIIA influences transplanted BMSCs' differentiation into neuronal cells in a rat SCI model. After SCI, rats received BMSCs, with or without TIIA treatment. Locomotor function and spinal cord regeneration were assessed. The study found that TIIA enhances the therapeutic effects of BMSC transplantation on SCI, likely by promoting the differentiation of BMSCs into neuronal cells.

Study Duration

28 days

Participants

56 Sprague-Dawley female adult rats

Evidence Level

Not specified

Key Findings

1
Rats treated with BMSCs and TIIA showed significantly higher locomotor scores compared to other groups.
2
The area of the cavity in the spinal cords of rats treated with BMSCs and TIIA was smaller than in other groups, indicating reduced tissue damage.
3
TIIA treatment decreased the number of transplanted BMSCs differentiating into astrocytes (GFAP+ cells) and increased the number differentiating into neuronal cells (Nestin+, NeuN+, NF200+).

Research Summary

This study investigates the potential of Tanshinone IIA (TIIA) to enhance the therapeutic effects of bone marrow mesenchymal stem cell (BMSC) transplantation in a rat model of spinal cord injury (SCI). The results indicate that TIIA treatment, combined with BMSC transplantation, significantly improves locomotor function and reduces tissue damage in SCI rats compared to control, TIIA alone, or BMSC alone groups. The study concludes that TIIA promotes the differentiation of transplanted BMSCs into neuron-like cells, suggesting a new therapeutic approach for SCI.

Practical Implications

Clinical Therapy

Combination therapy of TIIA and BMSC transplantation may be a novel therapeutic approach for SCI patients.

Stem Cell Differentiation Enhancement

TIIA can be used to enhance BMSC engraftment efficiency and promote their differentiation into neuronal cells.

Reduced Glial Scar Formation

TIIA can reduce glial scar formation, potentially improving neural regeneration after SCI.

Study Limitations

1
The underlying mechanisms of TIIA's beneficial effects are not fully elucidated.
2
The study did not thoroughly examine the modulation of secondary damage by TIIA and BMSCs.
3
There are no significant differences among the three treatment groups.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury